Core Viewpoint - The company has completed the registration of changes in business operations and has received a new business license, reflecting adjustments in its capital structure and share repurchase strategy [1][2]. Group 1: Company Actions - The company held meetings on October 30, 2025, and November 17, 2025, where it approved the adjustment of the purpose of 1,459,586 repurchased shares from employee stock ownership plans to cancellation and reduction of registered capital [1]. - The company has completed the necessary procedures for business registration changes and obtained a new business license from the Qingdao Administrative Approval Service Bureau [2]. Group 2: Company Information - The registered capital of the company is 316,492,922 yuan, and it was established on October 28, 2005 [2]. - The company operates in various sectors, including medical device research and development, production, sales, and after-sales services, as well as other technical services related to automation and information technology [2].
青岛海尔生物医疗股份有限公司关于完成工商变更登记并换发营业执照的公告